Decreased CP-1 (NF-Y) Activity Results in Transcriptional Down-Regulation of Topoisomerase IIα in a Doxorubicin-Resistant Variant of Human Multiple Myeloma RPMI 8226
- 1 August 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 237 (2) , 217-224
- https://doi.org/10.1006/bbrc.1997.7115
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Regulation of the Human Topoisomerase IIα Gene Promoter in Confluence-arrested CellsPublished by Elsevier ,1996
- Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceInternational Journal of Cancer, 1996
- The Cell Cycle-Coupled Expression of Topoisomerase IIα during S Phase Is Regulated by mRNA Stability and Is Disrupted by Heat Shock or Ionizing RadiationMolecular and Cellular Biology, 1996
- Molecular Cloning and Characterization of the Promoter for the Chinese Hamster DNA Topoisomerase IIα GenePublished by Elsevier ,1995
- Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.Proceedings of the National Academy of Sciences, 1991
- Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.Proceedings of the National Academy of Sciences, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.Proceedings of the National Academy of Sciences, 1988
- Recent studies of DNA topoisomerasesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1987
- Metaphase chromosome structureJournal of Molecular Biology, 1986